| Name | Title | Contact Details |
|---|---|---|
Greg Martini |
Vice President, Strategic Finance and Investor Relations | Profile |
Cheryl McCarthy |
Director, Research Quality Assurance | Profile |
Sharon DeBacco |
VP Product Promotion & Communication | Profile |
Alexander Bryant |
Vice President, Research and External Innovation | Profile |
Sravan Emany |
Chief Financial Officer | Profile |
MAIA Biotech is a targeted therapy, immuno-oncology company focused on the development and commercialization of first-in-class drugs
Avalyn is a biopharma company committed to developing improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. Our lead asset is inhaled pirfenidone (AP01) for the treatment of IPF. With offices in Seattle and San Diego, Avalyn`s experienced clinical and inhaled product development team is rapidly advancing AP01 for the treatment of IPF and additional pipeline candidates for IPF and other severe respiratory diseases.
LyGenesis is a biotechnology company with an organ regeneration technology platform enabling a patient`s lymph nodes to be used as bioreactors to regrow functioning ectopic organs.
OmniAb is a leading edge antibody discovery company that provides access to diverse antibody repertoires and high throughput screening technologies. They specialize in therapeutic antibody discovery using chickens as immunization hosts, which allows fo...
Ambit Biosciences is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.